Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -197.53 |
peg ratio | -9.57 |
price to book ratio | 462.59 |
price to sales ratio | 0.55 |
enterprise value multiple | 0.69 |
price fair value | 462.59 |
profitability ratios | |
---|---|
gross profit margin | 68.78% |
operating profit margin | -126.62% |
pretax profit margin | -90.57% |
net profit margin | -90.57% |
return on assets | -37.76% |
return on equity | -163.37% |
return on capital employed | -100.23% |
liquidity ratio | |
---|---|
current ratio | 1.52 |
quick ratio | 1.37 |
cash ratio | 0.35 |
efficiency ratio | |
---|---|
days of inventory outstanding | 188.40 |
operating cycle | 254.14 |
days of payables outstanding | 246.29 |
cash conversion cycle | 7.85 |
receivables turnover | 5.55 |
payables turnover | 1.48 |
inventory turnover | 1.94 |
debt and solvency ratios | |
---|---|
debt ratio | 0.56 |
debt equity ratio | 3.48 |
long term debt to capitalization | 0.68 |
total debt to capitalization | 0.78 |
interest coverage | -6.00 |
cash flow to debt ratio | -1.02 |
cash flow ratios | |
---|---|
free cash flow per share | -0.03 |
cash per share | 0.02 |
operating cash flow per share | -0.03 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -1.02 |
short term coverage ratios | -3.08 |
capital expenditure coverage ratio | -393.14 |
Frequently Asked Questions
BioLineRx Ltd. (BLRX) published its most recent earnings results on 30-09-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioLineRx Ltd. (NASDAQ:BLRX)'s trailing twelve months ROE is -163.37%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioLineRx Ltd. (BLRX) currently has a ROA of -37.76%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
BLRX reported a profit margin of -90.57% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.52 in the most recent quarter. The quick ratio stood at 1.37, with a Debt/Eq ratio of 3.48.